Patents Assigned to Merck Patents GmbH
  • Publication number: 20210024865
    Abstract: The invention provides a system for observation of media dissolution and/or bacterial growth in a transparent bag, comprising a receptacle for supporting the bag, and a light emitting device arranged to transmit light into and/or through the interior of the bag supported at the receptacle.
    Type: Application
    Filed: March 20, 2019
    Publication date: January 28, 2021
    Applicant: Merck Patent GmbH
    Inventors: Stephane OLIVIER, Gaetan BOUR
  • Publication number: 20210024481
    Abstract: The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
    Type: Application
    Filed: November 22, 2018
    Publication date: January 28, 2021
    Applicant: Merck Patent GmbH
    Inventors: Nils Koenen, Rouven Linge, Sebastian Meyer, Holger Heil
  • Publication number: 20210024826
    Abstract: The present invention relates to a method of manufacturing a liquid crystal display (LCD) of the polymer stabilized ultra fast (PS-UF) twisted nematic (TN) mode, to an LCD obtained by this method and to an LC medium used therein.
    Type: Application
    Filed: July 23, 2020
    Publication date: January 28, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Song (Shih-Hung) WANG, Eason (Chi-Shun) HUANG, Fred (Jer-Lin) CHEN, Ray (Kuang-Ting) CHOU
  • Publication number: 20210023087
    Abstract: A combination includes as a first active ingredient 6-fluoro-2-(4-morpholin-4-ylmethyl-phenyl)-quinoline-4-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide or a prodrug or pharmaceutically acceptable salt thereof and as a second active ingredient pyronaridine or a prodrug or pharmaceutically acceptable salt thereof. Also, a combination includes three antimalarial active ingredients, namely of 6-fluoro-2-(4-morpholin-4-ylmethyl-phenyl)-quinoline-4-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide or a prodrug or salt thereof, pyronaridine or pharmaceutically acceptable salt thereof, and artemisinin or derivatives thereof. Further, pharmaceutical compositions include such combination. The combinations and pharmaceutical compositions are useful for the treatment and/or prevention of malaria.
    Type: Application
    Filed: April 9, 2019
    Publication date: January 28, 2021
    Applicant: Merck Patent GmbH
    Inventors: Thomas Spangenberg, Claude Oeuvray, Nada Abla
  • Publication number: 20210023481
    Abstract: Filtration head (1) for a filter system, comprising base (2) including filter support (3) for removable filter element (4) and a fluid path from one side of filter element (4) on filter support (3), through filter element (4), and to drainage outlet (5) of base (2), and holder device (6) for removably attaching funnel (7) to base (2) to form a sample fluid reservoir on one side of filter element (4), wherein holder device (6) comprises ring-shaped element (8) configured to extend about bottom peripheral flange (7a) surrounding a lower end of funnel (7) and to selectively apply a biasing force on a radially outward protruding portion (7b) of bottom peripheral flange (7a) of funnel (7) to press funnel (7) against base (2). The filtration head allows the use of cardboard funnels without risk of liquid leakage between the funnel and the base.
    Type: Application
    Filed: April 3, 2019
    Publication date: January 28, 2021
    Applicant: MERCK PATENT GMBH
    Inventors: Didier METZ, Marisa HOHNADEL
  • Patent number: 10899852
    Abstract: The present invention relates to the use of hydrophilic compounds of the formula I as photopolymerisation initiators of polymerisable substance mixtures which comprise unsaturated compounds, or for the photochemical crosslinking of linear polymers, in which the parameters have the meaning indicated in Claim 1, to sealants for liquid-crystal displays which comprise the hydrophilic photoinitiators, to novel hydrophilic photoinitiators of the formula I, and to the liquid-crystal displays produced using these sealants.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: January 26, 2021
    Assignee: Merck Patent GmbH
    Inventors: Peer Kirsch, Qiong Tong, Alexander Hahn, Leo Weegels, Steffen Gnauck, Sven Schuepfer, Peter Leonhard, Claudia Enders
  • Patent number: 10903430
    Abstract: The present invention relates to compounds, compositions and formulations comprising same and to opto-electronic devices comprising the compounds and compositions according to the invention.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: January 26, 2021
    Assignee: Merck Patent GmbH
    Inventors: Anja Jatsch, Amir Hossain Parham, Thomas Eberle, Tobias Grossmann, Jonas Valentin Kroeber
  • Patent number: 10893675
    Abstract: The present invention relates to a powder formulation comprising at least one insect repellent and magnesium hydroxide carbonate, and to a process for the preparation of the formulation and to the use of the formulation for repelling insects.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: January 19, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Michael Termer, Frank Pfluecker, Lilia Heider, Alexandra Axt-Heidemann, Jutta Zur Lage
  • Patent number: 10894918
    Abstract: The present invention relates to a liquid crystal (LC) medium comprising polymerisable compounds, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, and to LC displays comprising it.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: January 19, 2021
    Assignee: Merck Patent GmbH
    Inventors: Melanie Klasen-Memmer, Nils Greinert, Matthias Bremer, Konstantin Schneider, Christian Schoenefeld, Thomas Bauer
  • Publication number: 20210009901
    Abstract: Liquid-crystal (LC) display devices comprising polymerisable compounds, processes and intermediates for the preparation of the devices and compounds, LC media comprising the compounds, and the use of the polymerisable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type.
    Type: Application
    Filed: July 21, 2020
    Publication date: January 14, 2021
    Applicant: Merck Patent GmbH
    Inventors: Dmitry USHAKOV, Kaja Christina DEING
  • Publication number: 20210008160
    Abstract: The present invention relates to polypeptides binding Aggrecan as well as ADAMTS5 and/or MMP13, more in particular to polypeptides that comprise or essentially consist of immunoglobulins binding Aggrecan as well as immunoglobulins binding ADAMTS5 and/or immunoglobulins binding MMP13 (also referred to herein as “polypeptides of the invention”, and “immunoglobulin(s) of the invention”, respectively).
    Type: Application
    Filed: June 4, 2018
    Publication date: January 14, 2021
    Applicants: Merck Patent GmbH, ABLYNX NV
    Inventors: Soren STEFFENSEN, Gerald BESTE, Hans GUEHRING, Lars TOLEIKIS, Christoph LADEL, Sven LINDEMANN, Roland KELLNER, Ralf GUENTHER
  • Patent number: 10892414
    Abstract: Described herein is a process for the preparation of an electronic device such as an organic electroluminescent device (OLED), wherein two adjacent functional layers having an interface are formed from solution in a kinetically controlled manner. The process is particularly suitable for fast and efficient production of electronic devices by printing or coating processes. The description further relates to an electronic device which is obtainable by said process.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: January 12, 2021
    Assignee: Merck Patent GmbH
    Inventors: Gaelle Béalle, Christoph Leonhard, Hsin-Rong Tseng, Manuel Hamburger, Beate Burkhart, Katja Maria Scheible, Anja Jatsch
  • Publication number: 20210002278
    Abstract: Compounds of the formula Ia or of the formula Ib in which X, Y, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Applicant: Merck Patent GmbH
    Inventor: Hans-Peter BUCHSTALLER
  • Patent number: 10883047
    Abstract: The invention relates to a liquid-crystalline medium, preferably having a nematic phase and dielectric anisotropy of 0.5 or more, which comprises one or more compounds of formula Y in which the parameters have the meanings given in the text, to the use thereof in an electro-optical display, particularly in an active-matrix display based on the IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the use of the compounds of formula Y for the improvement of the transmission and/or response times of a liquid-crystalline medium which comprises one or more additional mesogenic compounds.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: January 5, 2021
    Assignee: MERCK PATENT GMBH
    Inventor: Atsutaka Manabe
  • Publication number: 20200405674
    Abstract: The present invention relates to the use of serine or threonine together with at least one further amino acid or amino acid derivative and with at least one calcium salt or its hydrate to increase cellular availability of calcium in living cells of the epidermis and to a specific mixture of such components and a formulation consisting of said mixture and a solvent.
    Type: Application
    Filed: February 20, 2020
    Publication date: December 31, 2020
    Applicant: Merck Patent GmbH
    Inventors: Alexander Paul SCHILLER, Lisa ECKELHOEFER, Julia BLEIFUSS, Andrew Philip SALAZAR, Joerg von HAGEN
  • Publication number: 20200407640
    Abstract: LC media and LC displays containing an LC medium with positive dielectric anisotropy, which contains one or more compounds of formula I in a concentration of >0 and ?10% and displays addressed by an active matrix and in particular displays of the IPS, PS-IPS, FFS, PS-FFS, HB-FFS, U-IPS, TN, PS-TN, STN or TN-TFT mode.
    Type: Application
    Filed: June 26, 2020
    Publication date: December 31, 2020
    Applicant: MERCK PATENT GMBH
    Inventors: Yeon-Jeong HAN, Dong-Hyun KIM, Heui-Seok JIN, Chang-Suk CHOI
  • Patent number: 10879465
    Abstract: The present invention relates to a method for forming an organic element of an electronic device having at least two different pixel types including a first pixel type (pixel A) and a second pixel type (pixel B) wherein at least one layer of the pixel A and one layer of pixel B are deposited by applying an ink at the same time, characterized in that the ink for manufacturing a layer for the pixel A and the ink for manufacturing a layer for the pixel B which are deposited at the same time are different and the layer obtained by depositing the ink for manufacturing a layer for the pixel A and the layer obtained by depositing the ink for manufacturing a layer for the pixel B are dried thereafter, wherein the relative difference of the drying time (t1?t2/t1) of both layers being deposited at the same time and being obtained by two different inks for manufacturing a layer for the pixel A and a layer for the pixel B is at most 0.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: December 29, 2020
    Assignee: Merck Patent GmbH
    Inventors: Hsin-Rong Tseng, Thorsten Schenk, Peter Levermore, Anja Jatsch
  • Patent number: 10874615
    Abstract: The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: December 29, 2020
    Assignee: Merck Patent GmbH
    Inventors: Finn Bauer, Thorsten Wedel, Guenter Moddelmog, Gudrun Birk, Roberto Ognibene, Dieter Lubda
  • Patent number: D907170
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: January 5, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Gerald Lelong, Pascal Delahaie
  • Patent number: D907171
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: January 5, 2021
    Assignee: MERCK PATENT GMBH
    Inventors: Gerald Lelong, Pascal Delahaie